BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 20934286)

  • 1. [An update of Streptococcus pneumoniae: from genomic to clinic].
    Wintenberger C
    Med Mal Infect; 2010 Oct; 40(10):605-9. PubMed ID: 20934286
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimicrobial-resistant Streptococcus pneumoniae: trends and management.
    Jacobs MR
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):619-35. PubMed ID: 18847402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotype distribution and antimicrobial resistance of adult Streptococcus pneumoniae clinical isolates over the period 2001-2008 in Crete, Greece.
    Maraki S; Mantadakis E; Samonis G
    Chemotherapy; 2010; 56(4):325-32. PubMed ID: 20720416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumococcal resistance in the postvaccine era.
    Temime L; Guillemot D; Boëlle PY
    Pediatr Infect Dis J; 2006 Apr; 25(4):382-3. PubMed ID: 16568001
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
    Picazo JJ
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance.
    Arifeen SE; Saha SK; Rahman S; Rahman KM; Rahman SM; Bari S; Naheed A; Mannan I; Seraji MH; Ahmed NU; Hassan MS; Huda N; Siddik AU; Quasem I; Islam M; Fatima K; Al-Emran H; Brooks WA; Baqui AH; Breiman RF; Sack D; Luby SP
    Clin Infect Dis; 2009 Mar; 48 Suppl 2():S103-13. PubMed ID: 19191605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of invasive pneumococcal disease in Kumasi, Ghana.
    Holliman RE; Liddy H; Johnson JD; Adjei O
    Trans R Soc Trop Med Hyg; 2007 Apr; 101(4):405-13. PubMed ID: 17126867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance of Streptococcus pneumoniae infection during 1974-1981.
    Mihalcu F; Stănescu C; Mermezan E; Rusu V; Dorobăţ O; Cuciureanu G; Turcu T
    Arch Roum Pathol Exp Microbiol; 1983; 42(1):65-74. PubMed ID: 6336508
    [No Abstract]   [Full Text] [Related]  

  • 9. Surveillance for invasive Streptococcus pneumoniae disease among hospitalized children in Bangladesh: antimicrobial susceptibility and serotype distribution.
    Saha SK; Naheed A; El Arifeen S; Islam M; Al-Emran H; Amin R; Fatima K; Brooks WA; Breiman RF; Sack DA; Luby SP;
    Clin Infect Dis; 2009 Mar; 48 Suppl 2():S75-81. PubMed ID: 19191622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing epidemiology of invasive pneumococcal disease: a complicated story.
    Black S
    Clin Infect Dis; 2008 Aug; 47(4):485-6. PubMed ID: 18627248
    [No Abstract]   [Full Text] [Related]  

  • 11. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].
    Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pneumococcal disease and emergence of serotypes in the vaccine era. Transient trends and serotype replacement?].
    Moraga-Llop FA
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):1-4. PubMed ID: 19217995
    [No Abstract]   [Full Text] [Related]  

  • 13. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines.
    Lynch JP; Zhanel GG
    Curr Opin Pulm Med; 2010 May; 16(3):217-25. PubMed ID: 20375783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotics for childhood community-acquired pneumonia in a region with a high prevalence of penicillin non-susceptible Streptococcus pneumoniae.
    Lee WK; Young BW
    J Antimicrob Chemother; 2005 Sep; 56(3):603-5. PubMed ID: 16040621
    [No Abstract]   [Full Text] [Related]  

  • 15. Invasive pneumococcal disease in England and Wales: vaccination implications.
    Sleeman K; Knox K; George R; Miller E; Waight P; Griffiths D; Efstratiou A; Broughton K; Mayon-White RT; Moxon ER; Crook DW; ;
    J Infect Dis; 2001 Jan; 183(2):239-246. PubMed ID: 11120930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capsules, clones, and curious events: pneumococcus under fire from polysaccharide conjugate vaccine.
    Long SS
    Clin Infect Dis; 2005 Jul; 41(1):30-4. PubMed ID: 15937759
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccination with the pneumococcal 7-valent conjugate: a successful experiment but the species is adapting.
    Beall B
    Expert Rev Vaccines; 2007 Jun; 6(3):297-300. PubMed ID: 17542743
    [No Abstract]   [Full Text] [Related]  

  • 18. Promises and challenges of pneumococcal conjugate vaccines for the developing world.
    Grijalva CG; Edwards KM
    Clin Infect Dis; 2006 Sep; 43(6):680-2. PubMed ID: 16912938
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
    Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH
    Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive Streptococcus pneumoniae from Portugal: implications for vaccination and antimicrobial therapy.
    Serrano I; Ramirez M; Melo-Cristino J;
    Clin Microbiol Infect; 2004 Jul; 10(7):652-6. PubMed ID: 15214879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.